Ventripoint Diagnostics Ltd. (VPT.V ) applies of AI to echocardiography. Ventripoint's VMS products are powered by its proprietary KBR technology, which provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients.
Coverage was initiated August 2021 with updates in May 2022. and February 2023.
The company issued a corporate update today. Based on what has been delivered to the market to date, it's clear that adoption issues are present resulting in the absence in sales. As such, coverage will be put on hold.
DISCLAIMER: The work included in this article is based on current events, technical charts, and the author’s opinions. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. This publication contains forward-looking statements, including but not limited to comments regarding predictions and projections. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. The content of rally is provided for informational and entertainment purposes only and is not a recommendation to buy or sell any security. Always thoroughly do your own due diligence and talk to a licensed investment adviser prior to making any investment decisions - rally cannot take responsibility for your investment decisions.